Tag: Atrial Fibrillation
Deep Learning Model Predicts Atrial Fibrillation From Outpatient ECGs
Findings seen for atrial fibrillation in diverse populations
One-Third With Transient New-Onset A-Fib Have Recurrence
Recurrence within one year seen for 33.1 percent of those who have transient new-onset a-fib during hospitalization
Hypoattenuation Thickening on CT Prognostic After Left Atrial Appendage Occlusion
High-grade hypoattenuation thickening on follow-up CT after left atrial appendage occlusion associated with higher stroke risk
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
Significant reductions were seen in dementia risk for rivaroxaban, apixaban, and dabigatran versus warfarin in network meta-analysis
Psychosocial Stressors Tied to Incident Atrial Fibrillation in Postmenopausal Women
Analysis revealed two clusters of highly correlated psychosocial factors -- stress and strain
ESC: Catheter Ablation Aids Symptomatic Atrial Fibrillation, End-Stage Heart Failure
Patient benefits seen for all-cause mortality, implantation of a left ventricular assist device, or urgent heart transplantation
Catheter Ablation for Atrial Fibrillation Cuts Risk for Dementia, Death
Findings persisted across age, sex, and comorbidities
Incidence of A-Fib Reduced With Vitamin D₃ Supplementation
Risk for atrial fibrillation lower with 1,600 IU/day and 3,200 IU/day vitamin D3 supplementation
A-Fib Linked to Increased Odds of MCI, Dementia in Women
Women with atrial fibrillation and normal baseline cognition had higher risk of disease progression from normal to MCI, MCI to dementia
Early Treatment Can Be Initiated for A-Fib Patients With Stroke
Incidence of primary end point ranged from reduction of about 2.8 percent to increase of about 0.5 percent